Number (and proportion) of patients with local AE at the injection site in the safety population
| GO-ON (n=223) | Hyalgan (n=213) | p Value | |
|---|---|---|---|
| Joint effusion/swelling | 1 (0.4%) | 4 (1.9%) | |
| Joint pain | 3 (1.4%) | 2 (0.9%) | |
| Injection site haematoma | 0 (0.0%) | 2 (0.9%) | |
| Injection site warmth | 0 (0.0%) | 1 (0.5%) | |
| Total number of patients with any of the above local AE | 4 (1.8%) | 8 (3.8%) | 0.17 |
AE, adverse event.